White Mountains Insurance Group, Ltd. (WTM) Balance Sheet

The balance sheet has strengthened over the period, with equity rising steadily from $4.5B to $5.4B, reflecting retained earnings and capital gains. However, the path was non-linear, with a dip to $4.4B in 2024Q2 and a sharp jump to $5.4B in 2025Q4, suggesting a significant event such as favorable reserve development or investment gains. This growth appears to be driven more by investment performance and reserve releases than by core underwriting, as combined ratios have been highly volatile, ranging from -56.4% to 133.7%.

The investment portfolio line item shows a constant $1,000K, which is implausible for a company with $7.5B in assets, suggesting that the data may be incomplete or misreported. This lack of granularity prevents a thorough analysis of asset allocation, duration, or unrealized positions. Investors should monitor the actual investment portfolio composition, as it is the primary earning asset for an insurer, and the reported figures do not reflect the true scale or risk profile.

The claims and loss reserves line item shows considerable variability, with peaks in 2025Q3 ($397.3M) and 2024Q3 ($419.2M), and troughs in 2025Q4 ($195.4M). The negative combined ratio in 2025Q4 (-56.4%) strongly suggests favorable prior-year reserve development, which inflated earnings. This pattern implies that underwriting profitability is not stable and that reserve releases have been a key earnings driver, warranting scrutiny of reserve adequacy and the potential for future adverse development.

Equity has grown consistently, providing a stronger capital base, but liabilities have also risen, particularly in 2026Q1 when they reached $7.0B. The equity-to-assets ratio improved from 47% in 2024Q1 to 72% in 2026Q2, indicating a more conservative capital structure. However, the spike in liabilities in 2026Q1 suggests increased leverage or reserve funding, which could strain capital if underwriting results deteriorate. The company's ability to support buybacks, as evidenced by $190.9M in repurchases in 2026Q2, appears to be funded by this capital strength.

The absence of cash balance data limits direct liquidity assessment, but the cash flow statement reveals significant volatility in operating cash generation. In 2026Q2, operating cash flow was negative, while in 2025Q3 it was strongly positive, suggesting that the company relies on investment sales or external financing to cover short-term obligations during lean periods. This pattern may indicate that the claims-paying ability is dependent on the timing of premium collections and investment income, which could be a concern if a large catastrophe were to occur.